Asset sale Announced Sponsor buyer

Bridgepoint acquisition of Obagi Medical dermatological skincare and aesthetics business

Announced Jun 2026

Advisers

Obagi Medical dermatological skincare and aesthetics business

Target

Not disclosed

Other advisers

Financial adviser
Target
Obagi Medical dermatological skincare and aesthetics business
Acquirer
Bridgepoint
Seller
Waldencast
Target based in
United States (unverified)
Buyer based in
United Kingdom
Seller based in
United States (unverified)
Sector
Skin Care
Tags
Skin Care, Medical Aesthetics, Dermatology

In the league tables

Similar deals

All skin care deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.